1-11 of 11
Authors: William D. Figg
Save search
Sort by
Journal Article

Clinical trial results: each patient’s participation should count Open Access

PDF
William D Figg and Susan E Bates
The Oncologist, oyae252, https://doi.org/10.1093/oncolo/oyae252
Published: 24 September 2024
Journal Article

Relugolix in Clinical Practice: The Best Route for All? Get access

PDF
Lisa M Cordes and others
The Oncologist, Volume 28, Issue 8, August 2023, Pages 647–650, https://doi.org/10.1093/oncolo/oyad099
Published: 10 May 2023
Journal Article

Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer Get access

PDF
Ravi A Madan and others
The Oncologist, Volume 28, Issue 7, July 2023, Pages 642–e561, https://doi.org/10.1093/oncolo/oyad058
Published: 03 May 2023
Journal Article

Evidence Regarding Pharmacogenetics in Pain Management and Cancer Open Access

PDF
D Max Smith and William D Figg
The Oncologist, Volume 28, Issue 3, March 2023, Pages 189–192, https://doi.org/10.1093/oncolo/oyac277
Published: 30 January 2023
Journal Article

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide Get access

PDF
Keith T Schmidt and others
The Oncologist, Volume 27, Issue 9, September 2022, Pages 718–e694, https://doi.org/10.1093/oncolo/oyac100
Published: 30 May 2022
Journal Article

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma Get access

PDF
Cecilia Monge and others
The Oncologist, Volume 27, Issue 3, March 2022, Pages e273–e285, https://doi.org/10.1093/oncolo/oyab073
Published: 19 February 2022
Journal Article

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate Cancer Free

PDF
Lisa M. Cordes and others
The Oncologist, Volume 26, Issue 9, September 2021, Pages 729–e1493, https://doi.org/10.1002/onco.13919
Published: 14 August 2021
Journal Article

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma Free

PDF
Dickran Kazandjian and others
The Oncologist, Volume 26, Issue 4, April 2021, Pages 288–e541, https://doi.org/10.1002/onco.13712
Published: 10 March 2021
Journal Article

PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA Free

PDF
Emily N. Risdon and others
The Oncologist, Volume 26, Issue 1, January 2021, Pages e115–e129, https://doi.org/10.1634/theoncologist.2020-0697
Published: 08 September 2020
Journal Article

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma Free

PDF
Thomas S. Uldrick and others
The Oncologist, Volume 22, Issue 5, May 2017, Pages 505–e49, https://doi.org/10.1634/theoncologist.2016-0486
Published: 24 March 2017
Journal Article

Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis Free

PDF
Sarah M. Troutman and others
The Oncologist, Volume 17, Issue 3, March 2012, Pages 312–320, https://doi.org/10.1634/theoncologist.2011-0315
Published: 01 March 2012